Yüklüyor......
SGLT2 inhibitors: New medicines for addressing unmet needs in type 2 diabetes
The prevalence of type 2 diabetes mellitus (T2DM) is rising in Australia. Sodium glucose co-transporter 2 (SGLT2) inhibitors are an emerging treatment for T2DM. SGLT2 inhibitors offer a novel approach to lowering hyperglycaemia by suppressing renal glucose reabsorption and increasing urinary glucose...
Kaydedildi:
| Yayımlandı: | Australas Med J |
|---|---|
| Asıl Yazarlar: | , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Australasian Medical Journal
2014
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4221776/ https://ncbi.nlm.nih.gov/pubmed/25379062 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4066/AMJ.2014.2181 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|